EssilorLuxottica Decent end to FY23 investors assessing if the mid-term profitability guidance is achievable - Marketscreener.com
| 3218 Stock | TWD 217.50 11.00 5.33% |
Slightly above 55% of Universal Vision's sophisticated investors are presently thinking to get in. The analysis of current outlook of investing in Universal Vision Biotechnology suggests that some traders are interested regarding Universal Vision's prospects. Universal Vision's investing sentiment can be driven by a variety of factors including economic data, Universal Vision's earnings reports, geopolitical events, and overall market trends.
Universal Vision stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Universal daily returns and investor perception about the current price of Universal Vision Biotechnology as well as its diversification or hedging effects on your existing portfolios.
Universal |
EssilorLuxottica Decent end to FY23 investors assessing if the mid-term profitability guidance is achievable Marketscreener.com
Read at news.google.com
 |
Universal Vision Fundamental Analysis
We analyze Universal Vision's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Universal Vision using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Universal Vision based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Universal Vision is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Universal Vision Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Universal Vision stock to make a market-neutral strategy. Peer analysis of Universal Vision could also be used in its relative valuation, which is a method of valuing Universal Vision by comparing valuation metrics with similar companies.
Peers
Universal Vision Related Equities
| 9921 | Giant Manufacturing | 1.33 | ||||
| 6209 | Kinko Optical | 0.82 | ||||
| 1734 | Sinphar Pharmaceutical | 0.82 | ||||
| 3034 | Novatek Microelectronics | 0.21 | ||||
| 9908 | Great Taipei | 0.16 | ||||
| 2882A | Cathay Financial | 0.16 | ||||
| 3058 | Leader Electronics | 1.81 | ||||
| 6697 | Information Technology | 1.87 | ||||
| 5245 | WiseChip Semiconductor | 3.06 |
Additional Tools for Universal Stock Analysis
When running Universal Vision's price analysis, check to measure Universal Vision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Vision is operating at the current time. Most of Universal Vision's value examination focuses on studying past and present price action to predict the probability of Universal Vision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Vision's price. Additionally, you may evaluate how the addition of Universal Vision to your portfolios can decrease your overall portfolio volatility.